Brief: 4D Molecular Therapeutics Reports Third Quarter 2022 Financial Results

4D Molecular Therapeutics

09/11/2022 21:12

Nov 9 (Reuters) - 4D Molecular Therapeutics Inc
 FDMT.O :
    * 4D MOLECULAR THERAPEUTICS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE $239
MILLION AS OF SEPTEMBER 30, 2022
    * 4D MOLECULAR THERAPEUTICS - CASH, CASH EQUIVALENTS AND
MARKETABLE SECURITIES SUFFICIENT TO FUND OPERATIONS INTO THE
FIRST HALF OF 2025
    * 4D MOLECULAR THERAPEUTICS - QTRLY NET LOSS PER SHARE,
BASIC AND
DILUTED $0.79
    * Q4 EARNINGS PER SHARE VIEW $-0.80 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXJW9Jn 
Further company coverage:  FDMT.O 
 ((Reuters.Briefs@thomsonreuters.com;))